Search Results - "Strohmaier, C."

Targeted surface marker screening on neuronal structures in the human choroid by Wolfmeier, H., Heindl, S., Platzl, C., Kaser-Eichberger, A., Nematian-Ardestani, E., Strohmaier, C., Pruszak, J., Schroedl, F.

“…While choroidal neuronal control is known to be essential for retinal and ocular health, its mechanisms are not understood. Especially, the local choroidal…”
Get full text

Lymphatic markers in the human optic nerve by Trost, A., Runge, C., Bruckner, D., Kaser-Eichberger, A., Bogner, B., Strohmaier, C., Reitsamer, H.A., Schroedl, F.

“…Tissues of the central nervous system (CNS), including the optic nerve (ON), are considered a-lymphatic. However, lymphatic structures have been described in…”
Get full text

Time-dependent retinal ganglion cell loss, microglial activation and blood-retina-barrier tightness in an acute model of ocular hypertension by Trost, A., Motloch, K., Bruckner, D., Schroedl, F., Bogner, B., Kaser-Eichberger, A., Runge, C., Strohmaier, C., Klein, B., Aigner, L., Reitsamer, H.A.

“…Glaucoma is a group of neurodegenerative diseases characterized by the progressive loss of retinal ganglion cells (RGCs) and their axons, and is the second…”
Get full text

Response to the letter to the editor of Herwig-Carl et al by Trost, A., Runge, C., Bruckner, D., Kaser-Eichberger, A., Bogner, B., Strohmaier, C., Reitsamer, H.A., Schroedl, F.

Get full text

Lymphatic and vascular markers in an optic nerve crush model in rat by Trost, A., Bruckner, D., Kaser-Eichberger, A., Motloch, K., Bogner, B., Runge, C., Strohmaier, C., Couillard-Despres, S., Reitsamer, H.A., Schroedl, F.

“…Only few tissues lack lymphatic supply, such as the CNS or the inner eye. However, if the scleral border is compromised due to trauma or tumor, lymphatics are…”
Get full text

Patient and caregiver adherence and persistence to the rivastigmine patch in a non-interventional clinical study by Riepe, M, Weinman, J, Brady, R, Strohmaier, C, Mueller, B

Get full text

Ease of use of rivastigmine patch can help manage medication for caregivers and patients with Alzheimer's disease by Riepe, M, Weinman, J, Brady, R, Strohmaier, C, Mueller, B

Get full text

Predictors of response to the 13.3 and 9.5 mg/24 h rivastigmine patch: The optimizing /INS;transdermal exelon in mild-to-moderate Alzheimer's disease (optima) study by Molinuevo, J.L, Grossberg, G, Frölich, L, Galvin, J, Krahnke, T, Strohmaier, C

Get full text

High-dose 13.3 mg/24 h rivastigmine patch efficacy and safety in mild-to-moderate Alzheimer's disease with and without concomitant memantine use by Molinuevo, J.L, Cummings, J, Frölich, L, Galvin, J, Krahnke, T, Strohmaier, C

Get full text

Genetic testing in the context of familial hypercholesterolaemia: organisational and ethical aspects by Strohmaier, C, Walter, M

“…Background Molecular genetic diagnostics (GDx) is an increasingly used tool in the so-called ‘precision medicine'. For a structured implementation of GDx in…”
Get full text

Crown-of-Thorns Sea Star Acanthaster cf. solaris Has Tissue-Characteristic Microbiomes with Potential Roles in Health and Reproduction by Høj, Lone, Levy, Natalie, Baillie, Brett K, Clode, Peta L, Strohmaier, Raphael C, Siboni, Nachshon, Webster, Nicole S, Uthicke, Sven, Bourne, David G

“…Outbreaks of coral-eating crown-of-thorns sea stars (CoTS; species complex) cause substantial coral loss; hence, there is considerable interest in developing…”
Get full text

Methylcyclohexane Ring-Contraction:  A Sensitive Solid Acidity and Shape Selectivity Probe Reaction by McVicker, Gary B, Feeley, Owen C, Ziemiak, John J, Vaughan, David E. W, Strohmaier, Karl C, Kliewer, Wayne R, Leta, Daniel P

“…In this paper we describe the utility of an acid-catalyzed isomerization reaction, specifically, ring-contraction of methylcyclohexane to an isomeric mixture…”
Get full text

Biological and physical aspects of intraocular pressure by Reitsamer, H A, Bogner, B, Nischler, C, Strohmaier, C, Radner, W, Schroedl, F, Runge, C, Trost, A, Kiel, J W

“…A thorough understanding of intraocular pressure homeostasis is the biological foundation for the development of new strategies to treat patients with elevated…”
Get more information

Subconjunctival minimally invasive glaucoma surgery : Methods and clinical results by Lenzhofer, M, Hohensinn, M, Strohmaier, C, Reitsamer, H A

“…Minimally invasive glaucoma surgery (MIGS) has been developed for all drainage pathways in glaucoma treatment. Besides implants overriding the resistance in…”
Get full text

A splice variant of the neurotrophin receptor trkB with increased specificity for brain‐derived neurotrophic factor by Strohmaier, C., Carter, B. D., Urfer, R., Barde, Y. A., Dechant, G.

“…The trkB gene codes for a receptor tyrosine kinase, which is essential for the development of the peripheral nervous system. This receptor can be activated by…”
Get full text

A novel, microscope based, non-invasive laser Doppler flowmeter for choroidal blood flow assessment by Strohmaier, C., Werkmeister, R.M., Bogner, B., Runge, C., Schroedl, F., Brandtner, H., Radner, W., Schmetterer, L., Kiel, J.W., Grabner, G., Reitsamer, H.A.

“…Impaired ocular blood flow is involved in the pathogenesis of numerous ocular diseases like glaucoma or AMD. The purpose of the present study was to introduce…”
Get full text

High-dose 13.3mg/24h rivastigmine patch efficacy and safety in mild-to-moderate Alzheimer's disease with and without concomitant memantine use by Molinuevo, J.L., Cummings, J., Frölich, L., Galvin, J., Krahnke, T., Strohmaier, C.

Get full text

Predictors of response to the 13.3 and 9.5mg/24h rivastigmine patch: The optimizing /INS;transdermal exelon in mild-to-moderate Alzheimer's disease (optima) study by Molinuevo, J.L., Grossberg, G., Frölich, L., Galvin, J., Krahnke, T., Strohmaier, C.

Get full text

Managing Functional and Cognitive Decline in Patients with Mild-to-Moderate Alzheimer's Disease: A 48-Week, Randomized, Double-Blind Evaluation of 13.3 mg/24 h (15 cm{superscript 2}) Versus 9.5 mg/24 h (10 cm{superscript 2}) Rivastigmine Patch (P04.193) by Cummings, J., Frolich, L., Black, S., Bakchine, S., Bellelli, G., Molinuevo, J., Kressig, R., Downs, P., Caputo, A., Strohmaier, C.

“…Abstract only…”
Get full text

Intraocular pressure modulation by neuropeptides ‐ the effect of vasopressin by BOGNER, B, RUNGE, C, STROHMAIER, C, TROST, A, KASER‐EICHBERGER, A, KREFFT, K, GRABNER, G, KIEL, JW, SCHROEDL, F, REITSAMER, HA

“…Elevated intraocular pressure (IOP) is a major risk factor for glaucoma. Currently, the primary strategy to slow down glaucoma progression is IOP reduction…”
Get full text